ALM Ortho Secures $1 Million in Funding from Central TX Angel Network

ALM Ortho, a medical technology company tackling some of the challenges in orthopedic care, has raised $1 million in a Series A equity funding round led by the Central Texas Angel Network (CTAN) and Keiretsu Forum. This capital will accelerate the development and commercialization of ALM Ortho’s implant solutions, designed to improve outcomes for patients undergoing complex limb restoration surgeries.

Brian McLaughlin, Founder & Board Member, ALM Ortho, Inc. said, “Our technology focuses on cases where traditional options often fall short, leveraging osseointegration for limb reconstruction and joint arthroplasty revisions. By pushing the boundaries of what’s possible in limb restoration, we’re striving to improve lives and set a new standard of care.”

ALM Ortho’s technology focuses on osseointegration, limb lengthening, joint arthroplasty revisions, and trauma and provides solutions for those with limited options for limb restoration. The company collaborates directly with surgeons to create pioneering tools that can transform the standard of care. 

“While we always desire positive returns on our investments, it is especially gratifying to be part of enhancing the lives of people in our communities by funding cutting-edge technologies such as ALM Ortho.” Paul DeJuliis, Chairman and Co-Founder of ALM Ortho, commented, “This investment enables us to bring our innovative products to market faster, empowering surgeons to provide solutions that give patients a better chance at full recovery. We’re excited to take this next step in revolutionizing how complex limb restoration is approached.”

This funding will support the expansion of ALM Ortho’s product development pipeline and operational scaling. By pushing the boundaries of orthopedic technology, ALM Ortho is positioned to become a key player in advancing limb restoration techniques.